Related Experiment Videos

Enhanced prognostic stratification of patients with left ventricular hypertrophy with the use of single-photon

A M Amanullah1, D S Berman, X Kang

  • 1Departments of Medicine (Division of Cardiology) and Imaging, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

American Heart Journal
|August 31, 2000
PubMed

Insights

Myocardial perfusion SPECT effectively risk-stratifies patients with left ventricular hypertrophy (LVH), identifying those at high risk for cardiovascular events. This imaging technique adds crucial prognostic information beyond traditional clinical factors.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Diagnostic Imaging

Background:

  • Left ventricular hypertrophy (LVH) is associated with increased cardiovascular event risk.
  • Prognostic stratification in LVH patients using myocardial perfusion imaging is not well-established.

Purpose of the Study:

  • To evaluate the prognostic value of myocardial perfusion single-photon emission computed tomography (SPECT) for risk stratification in patients with LVH.

Main Methods:

  • A cohort of 633 patients with electrocardiographic LVH underwent dual-isotope myocardial perfusion SPECT.
  • Patients were followed for a mean of 22 months for major adverse cardiac events (cardiac death, nonfatal myocardial infarction).

Main Results:

  • The annual event rate was 6%, with significant risk stratification based on SPECT results.
  • Normal scans showed a low event rate (<1%), while abnormal scans had rates of 4.9% (mildly abnormal) and 10.3% (moderately to severely abnormal).
  • Summed stress score on SPECT provided significant incremental prognostic information beyond clinical variables.

Conclusions:

  • SPECT enhances prognostic stratification in LVH patients with high event rates.
  • Myocardial perfusion SPECT adds significant prognostic value beyond clinical and historical data for LVH patients.
Abstract

Related Concept Videos